• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETLW1620C156E
Medical Device Problem Code Difficult to Insert (1316)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/16/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
An endurant ii stent graft limb (b)(6) was intended to be implanted during the endovascular treatment of an abdominal aortic aneurysm.It was reported during the index procedure, the device was prepped normally, but when the device was placed over the wire it would not track over the wire.The wire would not go through the device.Multiple attempts were made to pass the wire through the device, but it was but it was unsuccessful.A replacement stent graft was implanted successfully, and the procedure was complete.Per the physician the cause of the difficultly to track the device was device related.No additional clinical sequelae were reported, and the patient is fine.
 
Additional Manufacturer Narrative
B5: additional information received: it was confirmed there was no damage noted to the device before use.It was handled properly without great force and flushed normally.It was a 0.35 (lunderquist) guidewire that was attempted to be loaded into the stent graft.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Device evaluation summary the delivery system returned with the external slider in the home position and the stent graft deployed.The device was flushed via the backend luer with water observed exiting the taper tip.Two kinks were visible on the graft cover and the spiral tubing underneath.A 0.035-inch guidewire was loaded via the taper tip and advanced; resistance was noted, and the guidewire could not advance past the kink.The guidewire was loaded via the backend luer and advanced; resistance was noted at the proximal kink and the guidewire could not be advanced past the kink.The reported insertion difficulties were confirmed based on the presence on kinks on the returned device.However, analysis could not determine if the kinks occurred pre or post attempted loading of the procedural guidewire.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II ILIAC STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key20235550
Report Number9612164-2024-04244
Device Sequence Number12890800
Product Code MIH
UDI-Device Identifier00643169467545
UDI-Public00643169467545
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 11/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/01/2025
Device Model NumberETLW1620C156E
Device Catalogue NumberETLW1620C156E
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/16/2024
Supplement Date Received by Manufacturer09/17/2024
11/21/2024
Initial Report FDA Received Date09/17/2024
Supplement Report FDA Received Date09/19/2024
11/28/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/02/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexMale
Patient Weight77 KG
-
-